Abstract
The T-cell derived cytokine CD40 ligand is overexpressed in patients with autoimmune diseases. Through activation of its receptor, CD40 ligand leads to a tumor necrosis factor (TNF) receptor 1 (TNFR1) dependent impairment of locomotor activity in mice. Here we report that this effect is explained through a promotion of sleep, which was specific to non-rapid eye movement (NREM) sleep while REM sleep was suppressed. The increase in NREM sleep was accompanied by a decrease in EEG delta power during NREM sleep and by a decrease in the expression of transcripts in the cerebral cortex known to be associated with homeostatic sleep drive, such as Homer1a, Early growth response 2, Neuronal pentraxin 2, and Fos-like antigen 2. The effect of CD40 activation was mimicked by peripheral TNF injection and prevented by the TNF blocker etanercept. Our study indicates that sleep-wake dysregulation in autoimmune diseases may result from CD40 induced TNF:TNFR1 mediated alterations of molecular pathways, which regulate sleep-wake behavior.
Copyright © 2012 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Monoclonal / pharmacology
-
Autoimmune Diseases / complications
-
Autoimmune Diseases / metabolism
-
Brain* / drug effects
-
Brain* / metabolism
-
C-Reactive Protein / drug effects
-
C-Reactive Protein / genetics
-
C-Reactive Protein / metabolism
-
CD40 Antigens / agonists
-
CD40 Antigens / metabolism*
-
Carrier Proteins / drug effects
-
Carrier Proteins / genetics
-
Carrier Proteins / metabolism
-
Early Growth Response Protein 2 / drug effects
-
Early Growth Response Protein 2 / genetics
-
Early Growth Response Protein 2 / metabolism
-
Electroencephalography / drug effects
-
Electromyography
-
Etanercept
-
Fos-Related Antigen-2 / drug effects
-
Fos-Related Antigen-2 / genetics
-
Fos-Related Antigen-2 / metabolism
-
Homer Scaffolding Proteins
-
Immunoglobulin G / pharmacology
-
Immunologic Factors / pharmacology
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Motor Activity / drug effects
-
Motor Activity / physiology
-
Nerve Tissue Proteins / drug effects
-
Nerve Tissue Proteins / genetics
-
Nerve Tissue Proteins / metabolism
-
Receptors, Tumor Necrosis Factor
-
Receptors, Tumor Necrosis Factor, Type I / drug effects
-
Receptors, Tumor Necrosis Factor, Type I / metabolism
-
Sleep / drug effects
-
Sleep / physiology*
-
Sleep Disorders, Circadian Rhythm / complications
-
Sleep Disorders, Circadian Rhythm / metabolism
-
Sleep, REM / drug effects
-
Sleep, REM / physiology
-
Tumor Necrosis Factor-alpha* / antagonists & inhibitors
-
Tumor Necrosis Factor-alpha* / drug effects
-
Tumor Necrosis Factor-alpha* / metabolism
Substances
-
Antibodies, Monoclonal
-
CD40 Antigens
-
Carrier Proteins
-
Early Growth Response Protein 2
-
Egr2 protein, mouse
-
Fos-Related Antigen-2
-
Fosl2 protein, mouse
-
Homer Scaffolding Proteins
-
Immunoglobulin G
-
Immunologic Factors
-
Nerve Tissue Proteins
-
Receptors, Tumor Necrosis Factor
-
Receptors, Tumor Necrosis Factor, Type I
-
Tnfrsf1a protein, mouse
-
Tumor Necrosis Factor-alpha
-
neuronal pentraxin
-
C-Reactive Protein
-
Etanercept